Mauriac Syndrome in a Nigerian child with Type 1 Diabetes Mellitus: A Case Report


  • IU Ezeani
  • EE Oyenusi



Abdominalswelling, Cachexia, Growth Failure, Hepatomegaly, Insulin, Pubertal delay


A 14-year-old boy with Type 1 Diabetes mellitus (diagnosed at eight years of age) presented with complaints of fever, weight loss, growth failure, pubertal delay, abdominal swelling and discomfort. He was on Premixed insulin (70/30) with inadequate follow-up and poor diabetic control. Examination revealed cachexia, generalised lymphadenopathy, a protuberant abdomen and hepatosplenomegaly. Anthropometry showed a bodyweight of 19.6kg, a height of 116cm and a BMI of 14.1kg/m2, all markedly below the 3rd centile. He had no secondary sexual characteristics: axillary hair stage 1, pubic hair stage 1, penile length of 4.9cm and prepubertal testicular volumes of 3mls bilaterally. At presentation, his random blood glucose was 400mg/dl, and glycosylated haemoglobin was 11.6%. Screening for tuberculosis, human immunodeficiency virus, hepatitis and lymphoproliferative disorders were negative. Other blood investigation findings included leucocytosis, erythrocyte sedimentation rate of 30mm/hr, normal liver function tests, normal serum electrolytes, urea and creatinine. His haemoglobin genotype was AS. Chest radiograph showed features of bronchopneumonia. A presumptive diagnosis of Mauriac Syndrome was made. With the optimisation of glycaemic control, he improved clinically with a weight gain of 5.7kg over four months and resolution of hepatosplenomegaly.


Lombardo L, Passanisi S, Gasbarro A, Tuccari G, Leni A, Salzano G. Hepatomegaly and type 1 diabetes: a clinical case of Mauriac’s syndrome. Ital J Paediatr 2019; 45: 1-6.

Fitzpatrick E, Cotoi C, Quaglia A, Sakellariou S, Ford-Adams ME, Hadzic N. Hepatopathy of Mauriac syndrome: a retrospective review from a tertiary liver centre. Arch Dis Child 2014; 99: 354–357.

Kocova M, Milenkova L. Old syndrome-new approach: Mauriac syndrome treated with continuous insulin delivery. SAGE Open Med Case Rep. 2018; 6: 1-4.

Munns CFJ, Mccrossin RB, Thomsett MJ, Batch J. Hepatic glycogenosis: Reversible hepatomegaly in type 1 diabetes. J Paediatr Child Health 2000; 36: 449–452.

Elder CJ, Natarajan A. Mauriac syndrome--a modern reality. J Pediatr Endocrinol Metab 2010; 23: 311-313.

Ferrer JC, Favre C, Gomis RR, Fernández-Novell JM, García- Rocha M, de la Iglesia N, et al Control of glycogen deposition. FEBS Lett 2003; 546: 127–132.

Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes. Medicine 1996; 75: 327–33.

MacDonald MJ, Hasan NM, Ansari IU, Longacre MJ, Kendrick MA, Stoker SW. Discovery of a genetic metabolic cause for Mauriac syndrome in type 1 diabetes. Diabetes. 2016; 65: 2051-2059.

Sherigar JM, Castro J, Yin YM, Guss D, Mohanty SR. Glycogenic hepatopathy: A narrative review. World J Hepatol 2018; 10:172-185.

Torbenson M, Chen YY, Brunt E, Cummings OW, Gottfried M, Jakate S, et al. Glycogenic hepatopathy: an under-recognised hepatic complication of diabetes mellitus. Am J Surg Pathol 2006; 30 (4): 508-513.

Gutch M, Philip R, Saran S, Tyagi R, Gupta KK. Re-emergence of a rare syndrome: A case of Mauriac syndrome. Indian J Endocrinol Metab 2013; 17: S283–S285.

Imtiaz KE, Healy C, Sharif S, Drake I, Awan F, Riley J, et al. Glycogenic hepatopathy in type 1 diabetes: an under-recognised condition. Diabetes Care 2013; 36: e6-e7.

Omer IM. Mauriac Syndrome: A diagnosis that still exists. Acad J Ped Neonatol 2017; 3: 0022.

Elamin A, Aitahir H, Ismail B, Tuvemo I. Clinical pattern of childhood Type 1 (insulin-dependent) diabetes mellitus in Sudan. Diabetologia 1992; 35: 645-648.

Suttorp M, Classen CF. Splenomegaly in Children and Adolescents. Front Pediatr 2021; 9: 704635.

Haftu H, Gebrearegay H, Berhane A. Malnutrition-Modulated Diabetes Mellitus in Children, Rare Disease with Atypical Presentation: Case Report. Diabetes, Metab Synd Obesity Targets Therapy 2020; 13: 3069–3074.

Mahmud FH, Elbarbary NS, Fröhlich-Reiterer E, Holl RW, Kordonouri O, Knip M et al. ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes 2018; 19: 275–286.






Case Report